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Abstract Idiopathic interstitialpneumonia (IIP) is a progressive interstitial lungdisease of unknownetiology.We inves-
tigateddendriticcellsinidiopathicnonspecific interstitialpneumonia (NSIP) immunohistochemically, usinganti-S-100pro-
tein antibody and anti-HLA-DR antibody and also evaluated the relationship betweenthe distribution of S-100 protein-
positive dendritic cells (S-100 DCs) and the lymphocytic subsets in the lung tissue of NSIP.Fifteenpatientswiththepatho-
logical diagnosis of idiopathic NSIP and six patientswith usual interstitial pneumonia (UIP) were recruited into this study.
Many S-100 DCs were observed in all the cases of idiopathic NSIP but S-100 DCs were not recognized in UIP cases
invariably. In the mirror section method, most S-100 DCs showed a positive reaction of anti-HLA-DR antibody but a
negative reaction for anti-CD1a antibody.CD8 and CD4 positive lymphocytes were infiltrated diffusely around S-100
DCs. It was demonstrated that the infiltration of CD8 positive lymphocytes predominated in the fibrosing areas and
lymphoid follicles around S-100DCsmore sothanCD4 positivelymphocytes.We speculatethatthepathogenesisofNSIP
is different from UIP and that DC and T cell-mediated immune mechanisms may play a role in the development and
perpetuation of NSIP.r2002 Elsevier Science Ltd.Allrights reserved
doi:10.1053/rmed.2002.1345, available online at http://www.idealibrary.comon
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Idiopathic interstitial pneumonia (IIP) is a progressive in-
terstitial lung disease of unknown etiology. Four histolo-
gically distinct forms of IIP comprise the morphologic
spectrum that has been traditionally included under the
designation of idiopathic pulmonary ¢brosis (1^3). This
classi¢cation scheme maintains the usual interstitial
pneumonia (UIP) and desquamative interstitial pneumo-
nia from Liebow’s original classi¢cation and includes two
additional entities, acute interstitial pneumonia and the
recently described idiopathic nonspeci¢c interstitial
pneumonia (NSIP). UIP is most commonly found in pa-
tients who present with chronic ¢brosing interstitial
pneumonia of unknown etiology. When ¢rst describedReceived 26October 2001, accepted in revised form 27 February 2002.
Correspondence should be addressed to:TakeoYoshinouchi,The
Second Department of Internal Medicine,Nagoya City University
Medical School,Mizyho-ku,Nagoya 467-8601, Japan.
Fax: 81052 852 0849in 1994, nonspeci¢c interstitial pneumonia was consid-
ered to be awastebasket term for all unclassi¢able inter-
stitial pneumonias (1). Since 1994, there have been seven
additional reports of NSIP and the concept of NSIP has
evolved from a broad, inclusive term into a speci¢c form
of idiopathic interstitial pneumonia (4^7). Histologically,
it is a uniform-appearing, cellular interstitial pneumonia
characterized by a lymphoplasmacytic in¢ltrationwithin
the alveolar septa. Varying amounts of ¢brosis are ad-
mixed with the chronic in£ammation (1^3). Unlike pa-
tients with UIP, the majority of patients with NSIP have
a goodprognosis, withmost showing improvement after
treatmentwith corticosteroids (1^7).Most cases of NSIP
are of unknown etiology and themechanism of ¢brosis is
unknown as in UIP.
Recently, Fujita showed that in 32% of patients with
idiopathic NSIP, autoantibodies were demonstrated un-
like in patients with UIP (6). An increase in lymphocytes
has been noted in bronchoalveolar lavage of patients
with NSIP (5,6).The majority of patients with NSIP have
S^100DCANDLYMPHOCYTESUBSETS INNSIP 771a goodprognosis, withmost showing improvement after
treatment with corticosteroids in contrast to UIP (1^7).
Because of these reasons, we speculate that the patho-
genesis of NSIP is di¡erent from UIP and that the ¢bros-
ingmechanism of NSIP is associatedwith immunological
mechanisms.
Dendritic cells are antigen presenting cells of hemo-
poietic origin. Only dendritic cells have the capacity to
activate naiveT cells. It is conceivable that dendritic cells
play an important role in immunological reactions.Taka-
hashi et al. and Nakajima et al. (8,9) reported that den-
drictic cells have S-100 protein, ¢rst introduced as being
speci¢c to nervous tissues, and suggested that the S-100
protein was also a distinguishing marker of these den-
drictic cells against conventional histocytes of mono-
cyte ^macrophage lineage containing lysozyme and
nonspeci¢c cross-reacting antigens. Some authors have
reported that dendritic cells are found in some respira-
tory diseases, for example, lung cancer (10), bronchial
asthma (11) and eosinophilic granuloma (12).Yoshinouchi
reported that S-100 protein-positive dendritic cells (S-
100 DCs) were found in interstitial pneumonia with UIP
patterns associatedwith rheumatoid arthritis (13).
We tried to investigate S-100 DCs in NSIP in compar-
isonwithUIP immunohistochemically, and also evaluated
the relationship between the distribution of S-100 DCs
and lymphocyte subsets in the lung tissue of NSIP.
MATERIALSANDMETHODS
Subjects
Between March 1990 and November 1997, 21 patients
with a pathological diagnosis of idiopathic NSIP and idio-TABLE 1. Clinical features of patientswith NSIP
Patients
no.
Age
(years)
Sex NSIP
group
WBC
(ml)
CRP
(mg/dl)
LDH
(IU/l)
%V
(%
1 60 M 2 5400 0.2 410 70.
2 51 F 2 6300 0.3 239 39.
3 66 M 2 10 900 22 441
4 74 M 2 5000 0.1 286 57.
5 52 F 2 7500 0.1 487 56
6 66 F 3 7300 0 558 83
7 60 M 2 or 3 8600 4 554 97.4
8 74 M 3 10 000 5.2 600 103
9 52 M 2 or 3 8300 0.6 381 93.
10 67 M 2 or 3 9700 0.1 600 138
11 62 F 2 7000 1.7 492 60
12 67 F 2 10 900 4.7 628 62.
13 69 M 2 4600 0.1 288 101
14 67 M 2 9800 2.8 251 70.
15 69 M 2 5000 0.1 408 71.3
WBC=white blood cell count; CRP=C-reactive protein; LDH
veolar lavage;Ly=lymphocytes; I=improvement;N=no change;pathic UIP by open lung biopsy were recruited into this
study.Table1shows clinical features of patientswithNSIP.
Fifteen patients with idiopathic NSIP consisted of nine
men and six women.The median age was 64 years ran-
ging from 51to 74 years.Cellular type was shown in 87%
(13/15) of patients and ¢brosing type was in 13% (2/15) of
patients.The six patients with UIP consisted of six men.
Themedian age of those patients with UIP was 70 years
ranging from 61to 76 years.None of the patients hadhis-
tories of occupational inhalation of dust.None of the pa-
tients had received immunosuppressive treatment such
as corticosteroid or cyclophosphamide at the time of
open lung biopsy. All pathological specimens were ana-
lyzed by lung pathologists according to the NSIP and
UIP criteria described by Katzenstein et al. (1^3).
Immunohistochemical staining and
evaluation
Sections of formalin-¢xed, para⁄n-embedded tissue
from each specimen were studied using the following
antibodies: polyclonal antibody to S-100 protein (Dako-
patts, Glostrup, Denmark), monoclonal antibodies to
HLA-DR alpha chain, anti-CD4 antibody (clone IF6, No-
vocastra), anti-CD8 antibody (clone 4B11, Novocastra),
anti-B cell antibody (anti-CD20, L26, DAKO) and anti-
CD1a antibody (O10, Immunotech).
The lung biopsy specimens were ¢xed in 10% neutral
bu¡ered formalin solution, cut into slices, embedded in
para⁄n and sectioned at 5mm for histological evaluation
and immunohistochemical staining. Immunohistological
staining was performed using the streptavidin/biotin/
peroxidase complex method. We tried the mirrorC
)
%DLCO
(%)
PaO2
(mmHg)
BAL,
Ly (%)
BAL,
OKT4/8 ratio
Prognosis
1 69 68 95 0.29 I
2 50 74.9 36 0.7 I
57.2 3 0.65 I
2 62 65.2 15 0.29 I
.7 85.7 88 20 0.37 I
62.1 66.5 8 1.85 N
80.2 80 21.4 1.91 N
132 79.4 13 1.02 N
3 102 91.9 0 0.08 N
116 62.7 29 7.93 N
.2 54.9 52.9 80 0.3 I
1 53 42 20 0.55 I
94.8 78.8 5 4.02 I
8 81 74.9 36 0.7 D
40.9 67 40 1.1 I
=lactic dehydrogenase;VC=vital capacity;BAL=broncho-al-
D=death.
772 RESPIRATORYMEDICINEsection method for evaluating the relationship between
S-100 DCs and HLA-DRa antibody positive cells or anti-
CD1a antibodypositive cells.Two consecutive 3mm-thick
sections were obtainedwith the cut surfaces facing each
other. Each section was then individually reacted with
anti-S-100 antibody, anit-HLA-DRa antibody or anti-
CD1a antibody as described above (14).
Thenumberof S-100DCs in each sectionwas assessed
using a semi-quantitative (0^4) scale, according to the
following criteria: 0=negative (no positive cells); 1+=oc-
casional (isolated positive cells irregularly distributed in
the ¢brosing areas without forming clusters); 2+=mod-
erate (small clusters of positive cells [o25 cells per clus-
ter] irregularly distributed and composingo25% of the
section); 3+=intense (large clusters of positive cells
[425% cells per cluster] and/or di¡use in¢ltrate) Periph-
eral nerves were excluded from the evaluation.
RESULTS
Distribution of S-100 DCs inNSIP andUIP
In the present study, we examined the distribution of S-
100 DCs in NSIP and UIP.Table 2 shows the results. Few
S-100 DCs were observed in the ¢brosing and honey-
combing areas of UIP [Fig. 1(A)]. Those cells observed
were small and had few cytoplasmic projections.On the
other hand, a large number of S-100 DCs with the same
features were found in most cases of NSIP [Fig. 1(B)].
Many S-100 DCs were large and irregular in form with
clear long cytoplasmic projections. The cytoplasm and
the nuclei of such cells were clearly and strongly positiveTABLE 2. The distribution of S-100 DCs and lymphocytes in N
Case S-100 DC CD4
1 1 Mild(D,F)
2 1 Mild(D)
3 1 Mild(D)
4 1 Moderate(F,D
5 1 Mild(D,F)
6 2 Mild(D,F)
7 3 Mild(D)
8 3 Mild(D)
9 3 Mild(D,F)
10 3 Moderate(D)
11 3 Mild(D)
12 3 Moderate(D,F
13 3 Moderate(D)
14 3 Mild(D,F)
15 3 Mild(D,F)
S-100 DCs scale; 0=negative; 1+=isolated positive cells 2+=s
clusters of positive cells [425% per cluster] and/or di¡use in¢l
phoid follicles.with S-100 protein antibody. The appearance of S-100
DCs occurred very often in the ¢brosing areas, where
aggregated lymphocytes or lymph follicleswere present.
A chi-square test showed signi¢cantly more S-100 DCs
in NSIP than in UIP (P=0.004).
Distribution of HLA-DRpositive or CD1a
positive S-100 DCs bymirror section
method
We examined the expression of HLA-DR antigen in S-
100 DCs. Many in¢ltrations of HLA-DR-positive cells
were shown in NSIP using anti-HLA-DR antibody. As
shown in Fig. 2, most S-100 DCs showed a positive reac-
tion for anti-HLA-DR antibody by the mirror section
method [Figs. 2(A) and (B)]. On the other hand, all the
S-100 DCs showed a negative reaction using anti-CD1a
antibody with themirror sectionmethod.
Relationship of S-100 DCs and lymphocyte
subsets
We also examined the distribution of lymphocyte sub-
sets and the relationship between those subsets and S-
100 DCs. CD4 positive T lymphocytes were in¢ltrated
di¡usely in the ¢brosing areas in all cases and inside and/
or around the lymphoid follicles in 53% (8/15) of cases.
The distribution of CD8 positive lymphocytes was
mostly di¡use in the ¢brosing areas in all cases, although
CD8 positive lymphocytes were in¢ltrated inside or
around the lymphoid follicles in 67% (10/15) of cases.
Many CD8 and CD4 positive lymphocytes were alwaysSIP
CD8 CD20
Moderate(D) Mild
Moderate(D) Mild
Abundant(D,F) Mild
) Abundant(D,F) Moderate
Moderate(D,F) Mild
Abundant(D,F) Mild
Moderate(D,F) Moderate
Abundant(D,F) Moderate
Abundant(D) Mild
Abundant(D) Mild
Moderate(D) Mild
) Abundant(D,F) Moderate
Abundant(D,F) Mild
Abundant(D,F) Mild
Abundant(D) Moderate
mall clusters of positive cells [o25 cells per cluster] 3+=large
trate D=di¡usely in ¢brosing areas, F=in¢ltrate around lym-
FIG. 1. Immunohistochemical staining by anti-S-100 antibody in IIP: (A) small simpli¢ed S-100 DC in UIP ( 240); (B) many large
irregularly shaped S-100 DCs andmany small simpli¢ed S-100 DCsin NSIP ( 220).
S^100DCANDLYMPHOCYTESUBSETS INNSIP 773in¢ltrated around S-100 DCs when S-100 DCs were ob-
served in the ¢brosing areas and lymphoid follicles
[Figs. 3(A)^(C)]. Itwas demonstrated that the in¢ltration
of CD8 positive lymphocytes predominated in the ¢-
brosing areas and lymphoid follicles around S-100 DCs,
much more than CD4 positive lymphocytes in all cases.
But, no correlation between the appearance of S-100
DCs, the distribution of lymphocyte subsets and theclin-
ical ¢ndings of NSIP could be demonstrated. The distri-
bution of B lymphocytes was restricted to inside and/or
around the lymphoid follicles and follicle-like structures
in all cases [Fig. 3(D)]. If the lymphoid follicles contained
a germinal center, the numbers of B lymphocytes in the
lung tissues were higher.
DISCUSSION
Considerable controversy exists as to the cause of IIP. A
lot of potential risk factors exist for IIP (14). One case-
control study has suggested an association between ex-
posure to antidepressants and the riskof developmentof
IIP. Chronic aspiration secondary to gastroesophageal
re£ux has been implicated in the development of IIP.Var-
ious environmental exposures in rural or agricultural
areas and in urban andmanufacturing settings havebeenlinked to the increasing risk of development of IIP in pa-
tients where a de¢nedpneumoconiosis was not present.
Hereditary factors may contribute to the risk factors of
IIP.Numerous viruses have been implicated in the patho-
genesis of IIP, but there remains no clear evidence of the
viral etiology. A higher incidence of Epstein-Barr virus,
in£uenza virus, cytomegalovirus and hepatitis Cvirus in-
fection has been reported in patients with IIP. In regard
to the immunological mechanism, there have been some
reports that a high frequency of IgG autoantibodies was
recognized in the plasma of patients with idiopathic pul-
monary ¢brosis (IPF) (16), and that the type 2 pattern of
cytokines appears to be predominant in IPF patients (17).
But there has been no report of NSIP patients and DCs.
Steinman et al. have established the concept that im-
munologically nativeT cells can be activated most e⁄-
ciently by a special subset of antigen presenting
leukocytes, termed DCs (18). DCs have been shown to
play essential roles in the induction of T-cell-mediated
immune reactions against a wide variety of antigens, in-
cluding foreignproteins and infectiouspathogens.Recent
studieshaverevealed several activities or properties that
allow DCs to perform those tasks e⁄ciently. For exam-
ple, DCs express relatively high levels of MHC class II
molecules and important co-stimulatory molecules, in-
cluding CD80, CD86 and CD40, equipping them to
FIG. 2. Double immunostain with anti-HLA-DR and anti-S-100 antibodies in NSIP by the mirror section method: (A) S-100 DCs
(arrowheads) were identi¢ed ( 220); (B) S-100 DCs (arrowheads) showed a positive reaction for anti-HLA-DR antibody ( 220).
774 RESPIRATORYMEDICINEdeliver T cell activation signals. DCs produce several
proin£ammatory and T-cell-stimulatory cytokines, for
example IL-12. DCs have been shown to play essential
roles in controlling di¡erentiation from nativeT cells to
Th1cells and Th2 cells.
S-100 protein was discovered in bovine brain by
Moore in 1965 (19), and was subsequently shown to be
widely distributed in various human tissues also. Human
lymphoreticular tissues, Langerhans’ cells of the skin, in-
terdigitating cells of the lymph nodes and some suppres-
sor/cytotoxicT cells are positive for S-100 protein (8,9).
In addition, the presence of S-100 DCs has also been re-
ported in various kinds of carcinoma and in£ammatory
diseases (12,14). In regard to interstitial pneumonia,Yoshi-
nouchi reported that pulmonary tissues from rheuma-
toid arthritis-associated intersitital pneumonia patients
containedmany cells positive for S-100 protein, but such
cells were hard to ¢nd in cases of IPF (13).However, there
hasbeen no reportof S-100DCs inNSIP and thepresent
study is the ¢rst report of S-100 DCs in NSIP. In the pre-
sent study, many S-100 protein and HLA DR antibody
positivebutCD1a anitbodynegativeDCswere observed
in the ¢brotic areas of NSIP, but such cells were hard to
¢nd in the ¢brotic areas and honeycombing areas of UIP.
It has been reported that Langerhans’cells showpositiv-ity for S-100 protein antibody and CD1a antibody, but in-
terdigitating dendritic cells (IDC) are S-100 protein
antibody positive and CD1a antibody negative (20). So,
those S-100 DCs observed in NSIP were thought to be
IDC. S-100 DCs have a pivotal role in initiating the im-
mune response andhavebeen identi¢ed in the target tis-
sues of several autoimmune diseases, including
rheumatoid arthritis, primary biliary cirrhosis, giant cell
arteritis and polyarteritis nodosa (21^24).Those ¢ndings
suggest that immunological mechanisms are involved in
NSIP and that the ¢brosingmechanism di¡ers fromNSIP
and IPF. The etiologic antigens of UIP and NSIP remain
unknown but numerous viruses have been implicated in
the pathogenesis of IIP. It may be considered that DCs
play essential roles in the induction of T-cell-mediated
immune reactions against such infectious pathogens or
type 2 pneumocytes in apoptosis following an unknown
mechanism.Nakao (25) reported that E-selectin expres-
sion on endothelial cells was restricted to the honey-
combing regions in the lung tissue from IPF. VCAM-1
was present on the endothelium of the venules and
capillaries in IIP. The expressions of E-selectin and
VCAM-1 on endothelial cells possibly play important
roles in the adhesion andmigration of DCs.Rosa (26) re-
ported that chronic in£ammationmight favor priming of
FIG. 3. Immunostainwithanti-S-100,CD4,CD8 andCD20 antibodiesinNSIP: (A)many S-100DCswereobserved ( 220); (B)CD4
positive lymphocyteswere in¢ltrated di¡usely around S-100 DCs ( 220); (C) many CD8 positive lymphocyteswere in¢ltrateddif-
fusely around S-100 DCs ( 220); (D) many CD20 positive lymphocyteswere observed in the lymphoid follicles ( 220).
S^100DCANDLYMPHOCYTESUBSETS INNSIP 775autoreactiveT cellswhich have escaped thymic tolerance
and are able to mount a cross-reactive response to self-
mimicking antigens carried by viruses in the periphery.
Moreover, chronic in£ammation and persisting viruses
can synergistically support autoimmunity through other
relevant mechanisms: unveiling of cryptic self-epitopes,
determinant spreading, activation of DCs, constant
priming of new autoreactiveT cells, and e⁄cient genera-
tion and restimulation of memory cells. It should be ta-
ken into consideration that the same mechanism is also
associated with the mechanism of IIP. In the present re-
port,we demonstrated that S-100DCs exist in lung spe-
cimens of NSIP. It is conceivable that chronic
in£ammation and persisting viruses can synergistically
support autoimmunity through activation of DCs with
regard to the mechanism of NSIP. Following this, an ef-
fort should be made to elucidate some facets of the
cause of inducing S-100 DCs to NSIP.
In the present study, one of the most important ¢nd-
ings was the distribution of lymphocytic subsets.Most B
lymphocytes were in¢ltrated in the lymphoid follicles. In
contrast, the distribution of CD4 and CD8 positive lym-
phocyteswasmostly di¡use in the ¢brosing areas and in-
side and/or around the lymphoid follicles, andmore CD8positive lumphocyteswere in¢ltrated around S-100 DCs
than CD 4 positive lymphocytes. In polyarteritis nodosa
and temporal arterities,T lymphocytes, especially those
belonging to the CD4 subset, were predominant in the
in¢ltrating cells around S-100DCs.This phenomenondif-
fers from the distribution of the lymphocyte subsets of
NSIP. S-100 DCs can play a leading role in the local CD4
positive and CD8 positive cytotoxic T cell activation.
Therefore, one can deduce that in NSIP, the processing
of endogenous antigens, including viruses and type 2
pneumocytes and so on, is intracellular. This process
may cause alveolitis by damage of the pneumocytes.
Thus, damaged epithelial cells may contribute to disor-
dered repair and chronic in£ammatory processes.
In conclusion, the distribution of CD4 and CD8
positive T lymphocytes was mostly di¡use in the
¢brosing areas and many CD4 and CD8 positiveT lym-
phocytes were in¢ltrated around S-100 DCs. S-100
DCs were observed in NSIP as well as rheumatoid ar-
thritis-associated interstitial pneumonia.The ¢nding sug-
gests that the pathogenesis of NSIP is di¡erent from UIP
and that DC and T-cell-mediated immune mechanisms
may play a role in the development and perpetuation
of NSIP.
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